Company Profile

Diopsys, Inc. is a leading provider of non-invasive medical devices that test for visual disorders that may affect the entire visual pathway. The company utilizes technology known as Visual Evoked Potential, or VEP. It is this technology that powers Diopsys, Inc.’s medical devices – the Enfant^® Pediatric VEP Vision Testing System and the Diopsys^® NOVA-VEP product series. Our patented technology has been demonstrated as an effective tool in the areas of vision screening for children, diagnosis and treatment of neurologically compromised patients, diagnosis and treatment for patients undergoing vision therapy, and an objective measurement of many ophthalmologic and optometric treatment plans.

The Enfant^® and Diopsys^® NOVA-VEP Vision Testing Systems have US FDA 510k clearance. In addition, Diopsys vision testing systems have been assessed and certified as meeting the requirements of Directive 93/42/EEC and ISO 13485:2003 for the design and manufacture of non-invasive diagnostic vision testing equipment and carry the CE mark allowing sales of its devices in the European Union (EU).

Our Mission

Diopsys, Inc. is a medical instrumentation company dedicated to advances in preventive health care. The company specializes in the development and marketing of easy-to-use, non-invasive, patient-friendly diagnostic testing equipment utilizing Visual Evoked Potential technology. Diopsys understands the needs of the patient, the parent, and the medical community, and the important role of early medical intervention for correctable health problems, which can lead to the improved quality of life.